2095432-55-4
2095432-55-4
Chemical Structure
SR-18292
- CAS No.: 2095432-55-4
- Formula:C23H30N2O2
- Molecular Weight:366.50
IUPAC Name: 1-((1H-indol-4-yl)oxy)-3-(tert-butyl(4-methylbenzyl)amino)propan-2-ol
InChIKey: BNRANURXPKRRKP-UHFFFAOYSA-N
SMILES: CC1=CC=C(CN(C(C)(C)C)CC(O)COC2=CC=CC3=C2C=CN3)C=C1
Biological Activity: SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SR-18292 | 99.87% | SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SR-18292 (Standard) | ≥98% | SR-18292 (Standard) is the analytical standard of SR-18292 (HY-101491). This product is intended for research and analytical applications. SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SR-18292-d9 | SR-18292-d9 is the deuterium labeled SR-18292 (HY-101491). SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
